Skip to main content
Premium Trial:

Request an Annual Quote

Seer: Omead Ostadan

Omead Ostadan will join Redwood City, California-based proteomics firm Seer as president and chief operating officer, effective June 29. He will also join the company's board of directors. Ostadan is currently chief product and marketing officer and a member of the executive management team of Illumina. He joined Illumina in 2007 as VP of marketing after the firm acquired Solexa, where he served in the same position. Prior to that, he held various marketing roles at Applied Biosystems. Ostadan holds a BS in biochemistry from the University of California, Davis, and an MBA from the Wharton School at the University of Pennsylvania.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.